Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
393 studies found for:    Endometrial Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Completed
Has Results
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Conditions: Neoplasms;   Neoplasms by Site;   Urogenital Neoplasms;   Genital Neoplasms, Female;   Uterine Neoplasms;   Endometrial Neoplasms;   Cancer of Endometrium;   Endometrial Cancer;   Cancer of the Endometrium;   Endometrium Cancer;   Neoplasms, Endometrial
Intervention: Drug: pemetrexed
22 Completed
Has Results
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Radiation: radiation therapy
23 Recruiting Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
Conditions: Breast Cancer;   Endometrial Cancer
Interventions: Other: HLA vaginal gel (HyaloGYN®),;   Behavioral: questionnaires
24 Withdrawn A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
25 Completed TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors
Condition: Endometrial Cancer
Interventions: Behavioral: Telemedicine Weight Management plus Wi-Fi Scale (Arm A);   Behavioral: Text for Diet (Text4Diet) Group (Arm B);   Behavioral: Enhanced Usual Care Group (Arm C)
26 Terminated Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: megestrol acetate;   Drug: paclitaxel;   Drug: tamoxifen citrate
27 Completed Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
28 Unknown  Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: aminopterin
29 Not yet recruiting VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer
Conditions: Endometrial Clear Cell Adenocarcinoma;   Endometrial Mixed Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Endometrial Undifferentiated Carcinoma;   Metastatic Endometrioid Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Recurrent Endometrial Serous Adenocarcinoma;   Recurrent Uterine Corpus Carcinoma;   Stage IV Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Procedure: Biopsy;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Planar Imaging;   Procedure: Single Photon Emission Computed Tomography;   Drug: Technetium Tc-99m Sodium Pertechnetate;   Biological: VSV-hIFNbeta-NIS
30 Recruiting Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin and paclitaxel;   Other: observation
31 Recruiting Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Abdominal total hysterectomy;   Procedure: Robot assisted laparoscopic hysterectomy
32 Unknown  Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer
Condition: Advanced or Recurrent Endometrial Cancer
Interventions: Drug: Doctaxel;   Drug: Cisplatin
33 Completed Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
34 Completed External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: Vaginal Brachytherapy
35 Unknown  Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin;   Drug: liposome-encapsulated doxorubicin citrate;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
36 Completed Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: erlotinib hydrochloride
37 Completed POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus
Conditions: Carcinoma, Endometrioid;   mTOR Protein
Intervention: Drug: Temsirolimus
38 Withdrawn Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Condition: Endometrial Cancer
Intervention: Drug: Metformin
39 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Radiation Therapy
40 Terminated Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: conjugated estrogens

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.